Final Programme Book and Congress App now available

The final programme book for ECTS 2017 in Salzburg is now available here. Have a look and plan your trip to Salzburg.

To assist you with this, the ECTS 2017 congress app is now available for download from all app stores. Just search for „ECTS Salzburg 2017“.

One download gets you:

  • Up-to-date programme, speaker and session information
  • Your own personalized schedule
  • All abstracts
  • Exhibition listing and venue floor plan
  • Social media conversations
  • Live chats with your peers
  • Venue and city information
  • …and much more!


EU Consortia Meetings

SYBIL SATELLITE MEETING Saturday May 13th 2017, Papageno Hall

Download programme


RUBICON SYMPOSIUM Tuesday May 16th 2017, 12:55-14:30

Hotel IMLAUER & Bräu Salzburg, Rainerstraße 12-14, Salzburg

12:55-13:00 Welcome remarks
Anna Teti (Italy), Bram van der Eerden (The Netherlands)

13:00-14:30 Scientific session
Chairs: Mike Briggs (UK), Malcolm Collins (South Africa)

13:00-13:30 Danny Chan (China)
Activating the unfolded protein response in osteocytes causes hyperostosis consistent with craniodiaphyseal dysplasia

13:30-14:00 Charles O’Brien (USA)
Osteocytes and RANKL

14:00-14:30 Paul Baldock (Australia)
Bone and energy metabolism

Medi-ManAge Innovation

Medi-ManAge Innovation in Mainz/Germany is an innovative and powerful company that specializes in the distribution and service of medical systems.

The main focus is the efficient probes and MRI coil repair, the osteology, pain therapy.

Here we offer you only the latest technologies and scientifically validated systems for diagnostics and therapy.

Through customer proximity, as well as a worldwide network with partners and access to more than 12,000 rental probes, we are in a position to help the users in practices and clinics in the shortest possible time.

In the service sector, our supervisors have many years of experience and in-depth knowledge, which are constantly updated through further training.


AGINKO Research is a premium CRO specialized in osteoarticular pathologies and medical device development.
Our team provides comprehensive preclinical and clinical trial management services in bone tissue repair, cartilage, spine, as well as in the inflammation and pain therapeutic areas to pharmaceutical, biotechnological and other musculoskeletal companies.
AGINKO specializes in tailoring each service to specific sponsor requirements while maintaining the strictest of ICH-GCP quality standards, regulatory requirements in adherence to regional guidelines.
What sets AGINKO apart is the unique approach to osteoarticular disease management and its large network of investigators that help our clients to achieve maximum value.


PolyGene is based in Switzerland. Founded in 2001, PolyGene is now one of the world top 5 professional transgenic service companies. For the generation of tailor-made animal models, PolyGene offers all standard services (classical transgenesis, blastocyst injection), but also state-of-the-art technologies such as CRISPR/Cas9, piggyBAC transgenesis, conditional and inducible gene knock-outs /-ins, gene humanization and cryopreservation. All services can be ordered in mice, but also in rats or rabbits. Inducible gene expression systems available at PolyGene allow to reversibly switch on/off gene expression in cell culture and in vivo, simply by adding or removing drugs such as RU486.

Special Discount for First-Timers from March 27-30

As first time participant at ECTS, if you register between 27 and 30 March 2017 you can benefit from the Early registration fee. Procedures:

  • Please register under the REGULAR FEE; at the end of the process please select the payment option “pay via bank transfer”
  • As soon as we verify that is the first time that you attend the ECTS congress, by 5 April the latest, we will contact you to send the payment details
  • Payment of the registration must be effective on 10 April the latest

Register here


Biomedica Immunoassays provides internationally recognized, high quality ELISAs for clinical research in the field of bone and mineral disorders as well as renal and cardiovascular diseases. Biomedica serves international academic scientific institutions, CROs, and laboratories in the pharmaceutical industry. All assays are fully validated according to ICH-Q2 guidelines and include serum-based calibrators and controls for biologically reliable data. New in the ELISA portfolio is Bioactive Sclerostin, soluble Semaphorin 4D, and Periostin. Since 2017, Biomedica exclusively distributes TAmiRNA’s osteomiR™ miRNA biomarker assay which serves as a novel fracture-risk assessment tool.
Visit us at our Biomedica booth # 9 (

1 2 3 6